Century Therapeutics (IPSC) Assets Average (2021 - 2026)

Century Therapeutics (IPSC) has 6 years of Assets Average data on file, last reported at $275.1 million in Q1 2026.

• Assets Average for Q1 2026 came in at $275.1 million, down 17.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $275.1 million (down 17.73% YoY), and the FY2025 annual result was $288.5 million, down 19.19% from the prior year.
• Assets Average improved to $275.1 million in Q1 2026 per IPSC's latest filing, from $234.2 million in the prior quarter.
• Over five years, Assets Average peaked at $541.4 million in Q2 2022 and troughed at $234.2 million in Q4 2025.
• A 5-year average of $392.4 million and a median of $382.5 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2025: Assets Average advanced 10.05% in 2022, then slumped 36.86% in 2025.
• A 5-year view of Assets Average shows it stood at $499.1 million in 2022, then declined by 24.05% to $379.1 million in 2023, then slipped by 2.16% to $370.9 million in 2024, then tumbled by 36.86% to $234.2 million in 2025, then gained by 17.47% to $275.1 million in 2026.
• Business Quant data shows IPSC's Assets Average at $275.1 million in Q1 2026, $234.2 million in Q4 2025, and $264.7 million in Q3 2025.